Segui
Antoine Abou Fayad
Titolo
Citata da
Citata da
Anno
Natural products from myxobacteria: novel metabolites and bioactivities
J Herrmann, A Abou Fayad, R Müller
Natural product reports 34 (2), 135-160, 2017
2682017
Heavy Metal Toxicity in Armed Conflicts Potentiates AMR in A. baumannii by Selecting for Antibiotic and Heavy Metal Co-resistance Mechanisms
W Bazzi, AG Abou Fayad, A Nasser, LP Haraoui, O Dewachi, ...
Frontiers in microbiology 11, 68, 2020
1172020
The generation of “unnatural” products: synthetic biology meets synthetic chemistry
RJM Goss, S Shankar, A Abou Fayad
Natural Product Reports 29 (8), 870-889, 2012
1162012
Genome-wide mutant profiling predicts the mechanism of a Lipid II binding antibiotic
M Santiago, W Lee, AA Fayad, KA Coe, M Rajagopal, T Do, F Hennessen, ...
Nature chemical biology 14 (6), 601-608, 2018
652018
Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its …
MJ Corr, SV Sharma, C Pubill-Ulldemolins, RT Bown, P Poirot, ...
Chemical Science 8 (3), 2039-2046, 2017
472017
Structure and Biosynthesis of Crocagins: Polycyclic Posttranslationally Modified Ribosomal Peptides from Chondromyces crocatus
K Viehrig, F Surup, C Volz, J Herrmann, A Abou Fayad, S Adam, J Köhnke, ...
Angewandte Chemie International Edition 56 (26), 7407-7410, 2017
462017
Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade
A Sleiman, AG Abou Fayad, H Banna, GM Matar
Journal of Global Antimicrobial Resistance 25, 209-221, 2021
302021
Engineering Atypical Tetracycline Formation in Amycolatopsis sulphurea for the Production of Modified Chelocardin Antibiotics
T Lukežič, AA Fayad, C Bader, K Harmrolfs, J Bartuli, S Groß, ...
ACS chemical biology 14 (3), 468-477, 2019
302019
Total biosynthesis of the pyrrolo [4, 2] benzodiazepine scaffold tomaymycin on an in vitro reconstituted NRPS system
A von Tesmar, M Hoffmann, J Pippel, A Abou Fayad, S Dausend-Werner, ...
Cell chemical biology 24 (10), 1216-1227. e8, 2017
262017
Biosynthesis of the Klebsiella oxytoca Pathogenicity Factor Tilivalline: Heterologous Expression, in Vitro Biosynthesis, and Inhibitor Development
A von Tesmar, M Hoffmann, A Abou Fayad, S Hüttel, V Schmitt, ...
ACS chemical biology 13 (3), 812-819, 2018
252018
Antimicrobial resistance and the Iraq wars: armed conflict as an underinvestigated pathway with growing significance
A Abou Fayad, A Rizk, S El Sayed, M Kaddoura, NK Jawad, A Al-Attar, ...
BMJ Global Health 7 (Suppl 8), e010863, 2023
242023
An unequivocal superbug: PDR Klebsiella pneumoniae with an arsenal of resistance and virulence factor genes
A Sleiman, B Awada, M Mocadie, N Sherri, LP Haraoui, V Baby, GF Araj, ...
The Journal of Infection in Developing Countries 15 (03), 404-414, 2021
202021
Phenotypic and Genotypic Characterization of Extended‐Spectrum Beta‐Lactamases Produced by Escherichia coli Colonizing Pregnant Women
N Ghaddar, E Anastasiadis, R Halimeh, A Ghaddar, GM Matar, ...
Infectious diseases in obstetrics and gynecology 2020 (1), 4190306, 2020
192020
Antimicrobial resistance in the ongoing Gaza war: a silent threat
K Moussally, G Abu-Sittah, FG Gomez, A Abou Fayad, A Farra
The Lancet 402 (10416), 1972-1973, 2023
182023
Natural products and polysorbates: Potential Inhibitors of biofilm formation in Pseudomonas aeruginosa
M Miari, SS Rasheed, NH Ahmad, D Itani, A Abou Fayad, GM Matar
The Journal of Infection in Developing Countries 14 (06), 580-588, 2020
162020
Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
B El Hafi, SS Rasheed, AG Abou Fayad, GF Araj, GM Matar
Frontiers in Microbiology 10, 933, 2019
152019
Octapeptins: lipopeptide antibiotics against multidrug-resistant superbugs
A Abou Fayad, J Herrmann, R Müller
Cell chemical biology 25 (4), 351-353, 2018
132018
Drosophila melanogaster as a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases
JR Madi, AA Outa, M Ghannam, HM Hussein, M Shehab, ZAKH Hasan, ...
Frontiers in Immunology 12, 586930, 2021
122021
Clinical predictors of mortality in patients with pseudomonas aeruginosa infection
JA Frem, G Doumat, J Kazma, A Gharamti, SS Kanj, AG Abou Fayad, ...
Plos one 18 (4), e0282276, 2023
92023
The under investigated facet of the COVID-19 pandemic: Molecular analysis of secondary bacterial infections at a COVID dedicated intensive care unit within a tertiary care …
A Sleiman, P Abdelkhalek, G Doumat, F Atallah, L Hamadeh, P Moussa, ...
Frontiers in Medicine 10, 1001476, 2023
92023
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20